Just Other Articles

One might be wondering why some lenders turn down a mortgage application while some others might consider it fit for approval. The answer may well lie in the credit report and the credit score to be precise which plays a c

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

rucial role in loan sanctioning.

Credit history is an important factor affecting loan granting decisions by the lender or mortgagee. As part of the pre-approval process a detailed investigation is carried out into your fi

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

nancial history whereby the lender assesses your finances, your credit history and your investments. Your debt ratios are compared with the lender’s standard while deciding on the loan approval. Your level of debt or credi

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

t history is taken as a parameter for judging your ability to make the monthly repayments. The credit history as represented by your credit report plays a very crucial role since some lending institutions may even turn you

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

down because of incompatibility with their lending standards. Too much debt and poor credit rating is a common reason cited for turning down a mortgage application.

At times your application may not be rejected altogethe

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

r but you may have to settle for a loan amount lower than what you desired or expected. The other terms and conditions of the loan might also not have proved worthwhile for you. All these could have been avoided had you be

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

en a little more careful and vigilant while placing your documents about your personal finances as reflected by records of your earnings, monthly expenses and debts. Among these documents the credit report is of prime impo

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

rtance which reveals your credit score.

While considering your application the lender will also get to analyze your credit report. This provides all details about your financial history, payment records, total debts and b

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ankruptcies (if any). This information is used to work out your credit score or FICO score (a rating of Fair Isaac and Company). This is a composite number-a numerical rating of your credit worthiness. These scores may ran

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ge from 300-900. However, most people’s score fall between 600 and 700. Higher credit scores make you more appealing to the lender. Thus, you will be more likely to be offered better rates and loan terms.

A number of fact

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

rs can affect the credit score. They can be broadly classified as:

a) The length of time you have had credit, outstanding credit, methods to repay this and how close you are to your credit limits.

b) Problems with credit

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

which you may be having like late payments and bankruptcies. The number and frequencies of your delinquencies is to be considered.

It may be noted that almost 80% of credit reports contain errors. Getting for yourself a

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

copy of the report beforehand will enable you to take steps for improving your score.You will be availed of the opportunity to review the report and rectify the score to quite an extent.

Some steps which can be taken in t

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

his regard are:

a) Finding out credit cards which are not needed anymore and closing the corresponding credit accounts.

b) Settling outstanding accounts, if any.

c) Paying out your bills, debt payments on time and in fu

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

ll and reduce your outstanding credit.

d) Verifying all listed account numbers and getting assured that they are yours.

It may be noted that minor credit problems or problems cropping up due to illnesses or temporary los

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

s of income due to some unpredictable occurrence will restrict your chances of getting the aspired loan only from some high-cost lenders. Other lenders will hopefully be considerate enough to overlook such minor problems.

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

In spite of the best efforts there may still be certain negative indications in the report which could not be done away with. In such case you need to explain the situation to the lender. If at all it cannot be explained

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

then, perhaps, you have to make greater down payments.

Getting to know how credit record affects loan prospects, proceed towards making improvements in your credit report. Your loan prospects will improve, no doubt. It wi

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ll take you a long way towards securing your desired mortgage loan.

For getting all possible help in obtaining your suitable mortgage visit: http://www.mortgagefit.com/<

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

/a>

Gain all round knowledge and obtain guidance regarding the mortgage application process from:

http://www.mortgagefit.com/discuss/forum-2.html

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Need a great resume to land that great job coming up? We are going to learn to create an eye-catching resume, using Microsoft Word. First, you need to collect all the information you will need to c...

Have you ever considered how smaller businesses and even franchisees who own franchised outlets are hurt in economic downturns? Have you ever considered the ebb and flow of regulations and how they try to control it? We all know that the government does nothing very well and yet we allow them to try to reign in the cattle and corral the raging rapids of our economy. Why?

Tags

Links

Just Other Articles - Understand Credit Report's Relevance In Mortgage

Related Articles: